Buchumschlag

Rational design of protein kinase inhibitors

Modern methodological approaches to rational design of low molecular weight compounds with specific activity in relation to predetermined biomolecular targets are considered by example of development of high effective protein kinase inhibitors. The application of new computational methods that allow...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Вiopolymers and Cell
Datum:	2013
Hauptverfasser:	Yarmoluk, S.M., Nyporko, A.Yu., Bdzhola, V.G.
Format:	Artikel
Sprache:	Englisch
Veröffentlicht:	Інститут молекулярної біології і генетики НАН України 2013
Schlagworte:	Reviews
Online Zugang:	https://nasplib.isofts.kiev.ua/handle/123456789/152995
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:	Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:	Rational design of protein kinase inhibitors / S.M. Yarmoluk, A.Yu. Nyporko, V.G. Bdzhola // Вiopolymers and Cell. — 2013. — Т. 29, №. 4. — С. 339-347. — Бібліогр.: 44 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine

Ähnliche Einträge

Rational design of protein kinase inhibitors
von: S. M. Yarmoluk, et al.
Veröffentlicht: (2013)

Evaluation of 4H-4-chromenone derivatives as inhibitors of protein kinase CK2
von: Prykhodko, A.O., et al.
Veröffentlicht: (2005)

Quinazoline inhibitors of protein kinase FGFR1
von: A. A. Hryshchenko, et al.
Veröffentlicht: (2010)

Design and study of telomerase inhibitors based on G-quadruplex ligands
von: Negrutska, V.V., et al.
Veröffentlicht: (2013)

Effect of protein kinase CK2 inhibitors on its catalytic subunits SK2α and SK2α´
von: O. V. Ostrynska, et al.
Veröffentlicht: (2014)

Search of protein kinase CK2 inhibitors based on purine-2,6-diones derivatives
von: M. V. Protopopov, et al.
Veröffentlicht: (2017)

Synthesis and biological evaluation of novel amino-substituted derivatives of pyrido[2,3-d]pyrimidine as inhibitors of protein kinase CK2
von: Zinchenko, A.N., et al.
Veröffentlicht: (2017)

The inhibitor of apoptosis (IAP) proteins are critical regulators of signaling pathways and targets for anti-cancer therapy
von: de Almagro, M.C., et al.
Veröffentlicht: (2012)

Structural and functional peculiarities of plasminogen activator inhibitor PAI-1
von: Zhernossekov, D.D., et al.
Veröffentlicht: (2010)

Influence of tyrosine proteine kinases inhibitor, genestein, on Agrobacterium – mediated plant transformation
von: V. Fedorchuk, et al.
Veröffentlicht: (2015)

Variability of DNA structure and protein-nucleic acid reconginition
von: Boryskina, O.P., et al.
Veröffentlicht: (2010)

Specific features of protein biosynthesis in higher eukaryotes
von: El'skaya, A.V., et al.
Veröffentlicht: (2013)

Protein isoforms. Origin, structure and functions
von: Novosylna, O.V.
Veröffentlicht: (2017)

Fluorescence tools for studies of membrane protein insertion
von: Kyrychenko, A.V., et al.
Veröffentlicht: (2018)

Hematological effects of the protein kinases inhibitor maleimide derivative of dimethylhydrazineinduced colorectal carcinogenesis of rats
von: I. V. Bielinska, et al.
Veröffentlicht: (2014)

Protein splicing and its evolution in eukaryotes
von: Starokadomskyy, P.L.
Veröffentlicht: (2010)

Effect of inhibitors serine/threonine protein kinases and protein phosphatases on mitosis progression of synchronized tobacco BY-2 cells
von: Ja. A. Sheremet, et al.
Veröffentlicht: (2012)

Integration of autography, proteasomal degradation, unfolded protein responce and apoptosis
von: Benbrook, D.M., et al.
Veröffentlicht: (2012)

Janus kinase inhibitors in dermatology: present and future
von: I. M. Serbina, et al.
Veröffentlicht: (2021)

Current scenario on computer-aided metalloenzymes designing
von: Chellapandi, P.
Veröffentlicht: (2011)

InsIghts Into the mechanIsm of natural terpenoIds as NF-κB InhIBItors: an overvIew on theIr antIcancer potentIal
von: Jain, H., et al.
Veröffentlicht: (2016)

An inhibitor of Ca2+-dependent protein kinases, trifluoperazine, increases the efficiency of agrobacterium-mediated transformation of tobacco
von: V. V. Fedorchuk, et al.
Veröffentlicht: (2014)

Tyrosine kinase inhibitors in treatment of fibrous histiocytoma
von: Maur, D., et al.
Veröffentlicht: (2009)

Zinc ribbon domain containing 1 protein: modulator of multidrug resistance, tumorigenesis and cell cycle
von: Hong, L., et al.
Veröffentlicht: (2006)

Hit identification of FGFR1 inhibitors using receptor-based virtual screening
von: Tarnavskiy, S.S., et al.
Veröffentlicht: (2019)

Hit identification of CK2 inhibitors by virtual screening
von: Protopopov, M.V., et al.
Veröffentlicht: (2017)

Protein inhibitors synthesised by microorganisms
von: E. V. Matseljukh, et al.
Veröffentlicht: (2013)

Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome
von: Grybach, S.M., et al.
Veröffentlicht: (2018)

Cyclin-dependent kinases 4/6 inhibitors in combination with aromatase inhibitors in treatment of metastatic breast cancer (clinical observation)
von: M. V. Sadchykova, et al.
Veröffentlicht: (2020)

The function of poliamine metabolism in prostate cancer
von: Palavan-Unsal, N., et al.
Veröffentlicht: (2006)

Carbon adsorbents in oncology: achievements and perspectives
von: Nikolaev, V.G., et al.
Veröffentlicht: (2011)

Protein kinase Akt activity in human thyroid tumors
von: B. B. Guda, et al.
Veröffentlicht: (2016)

The search for potential inhibitors of protein kinase Pim-1 among new amides of 1,2,4-triazolo|4,3-a|pyridine-3-metanamin with the 1,2,4-oxadiazol cycle in position 7 and 8The search for potential inhibitors of protein kinase Pim-1 among new amides of 1,2
von: V. R. Karpina, et al.
Veröffentlicht: (2019)

Chronic periodontitis and the risk of head and neck squamous cell carcinoma: facts and figures
von: Gondivkar, S.M., et al.
Veröffentlicht: (2013)

Prediction of protein-ligand binding sites modulating activity of MAST protein kinases
von: P. A. Karpov, et al.
Veröffentlicht: (2024)

Effects of tyrosine kinase and phosphatase inhibitors on mitosis progression in synchronized tobacco BY-2 cells
von: Ya. A. Sheremet, et al.
Veröffentlicht: (2012)

Effects of tyrosine kinase and phosphatase inhibitors on mitosis progression in synchronized tobacco BY-2 cells
von: Sheremet, Ya.A., et al.
Veröffentlicht: (2012)

Mitochondrial genetic transformation via biotechnological approaches or natural competence mechanism: do we have a choice?
von: Koulintchenko, M.V., et al.
Veröffentlicht: (2012)

Generation of monoclonal antibodies specific to ribosomal protein S6 kinase 1
von: L. O. Savinska, et al.
Veröffentlicht: (2012)

Novel epigenetic markers of early epithelial tumor growth and prognosis
von: Gordiyuk, V.V., et al.
Veröffentlicht: (2013)